End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.96 DKK | +0.20% | +9.45% | -43.89% |
04-16 | Curasight A/S Announces Approval of Clinical Trial Application for Phase 2 Trial with uTRACE in Prostate Cancer Patients | CI |
04-12 | Curasight A/S Announces Board Changes | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.89% | 28.61M | |
+24.21% | 47.9B | |
+46.90% | 41.42B | |
-2.99% | 40.7B | |
-6.20% | 28.92B | |
+8.97% | 25.55B | |
-20.68% | 19.27B | |
-0.04% | 12.15B | |
+28.37% | 12.14B | |
-0.34% | 11.99B |
- Stock Market
- Equities
- CURAS Stock
- News Curasight A/S
- Curasight A/S Appoints Kirsten Drejer as New Member of the Board of Directors